Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Finasteride helps female-pattern hair loss.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Targeting Midkine can help reduce pain and itching in keloids.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Stress hormones like cortisol may trigger psoriasis flare-ups.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Pro-Ile could be used in cosmetics to improve skin, hair growth, and healing.

ELL is crucial for gene transcription related to skin cell growth.

Collagen XVII is crucial for preventing hair and pigmentation loss by maintaining melanocyte stem cells.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

Integrin-linked kinase is crucial for melanoblasts to properly colonize the skin.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Collagen XVII is important for cell functions and its absence can worsen cancer outcomes.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

The PML protein helps prevent skin cancer in mice.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Inflammation is linked to hair loss.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.